Is psychotic disorder associated with increased levels of craving for cannabis? An Experience Sampling study

Acta Psychiatrica Scandinavica

Volumn 128, Issue 6, 2013, Pages 448-456

  Kuepper, R ^a   Oorschot, M ^a   Myin Germeys, I ^a,c   Smits, M ^b   Van Os, J ^a,d   Henquet, C ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Mondriaan ^*  (Netherlands)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabis use; Craving for cannabis; Experience sampling method; OCDUS; Psychotic disorder; Schizophrenia

Indexed keywords

CANNABIS;

ADDICTION SEVERITY INDEX; ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HALLUCINATION; HUMAN; MALE; MOTIVATIONAL INTERVIEWING; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; WITHDRAWAL SYNDROME;

CANNABIS USE; CRAVING FOR CANNABIS; EXPERIENCE SAMPLING METHOD; OCDUS; PSYCHOTIC DISORDER; SCHIZOPHRENIA;

ADULT; CANNABIS; COMORBIDITY; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX;

EID: 84887406656     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12078     Document Type: Article

References (30)

1. Gregg L, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis. Clin Psych Rev 2007;27:494-510.
2. Green B, Young R, Kavanagh D. Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatry 2005;187:306-313.
3. Zammit S, Moore TH, Lingford-Hughes A et al. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 2008;193:357-363.
4. Opsal A, Clausen T, Kristensen O, Elvik I, Joa I, Larsen TK. Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up. Acta Psychiatr Scand 2011;124:198-204.
5. Barrowclough C, Haddock G, Wykes T et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed) 2010;341:c6325.
6. Franken IH. Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog Neuro-psychoph Biol Psychiatry 2003;27:563-579.
7. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res 1993;18:247-291.
8. Dekker N, Koeter M, Van Den Brink W, GROUP Investigators Craving for cannabis in patients with psychotic disorderd, their non-affected siblings and healthy controls: psychometric analysis of the Obsessive Compulsive Drug Use Scale. Int J Meth Psych Res 2012;21:286-300.
9. Machielsen M, Scheltema Beduin A, Dekker N et al. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. J Psychoph 2012;26:189-195.
10. Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry 1998;3:123-134.
11. Anton RF, Moak DH, Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 1995;19:92-99.
12. Mcguffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991;48:764-770.
13. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989;155:59-67.
14. Mclellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise D. The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addict 2006;15:113-124.
15. Rikoon SH, Cacciola JS, Carise D, Alterman AI, Mclellan AT. Predicting DSM-IV dependence diagnoses from Addiction Severity Index composite scores. J Subst Abuse Treat 2006;31:17-24.
16. Oorschot M, Kwapil T, Delespaul P, Myin-germeys I. Momentary assessment research in psychosis. Psychol Assessment 2009;21:498-505.
17. Myin-germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, Van Os J. Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med 2009;39:1533-1547.
18. Delespaul P. Empirical studies in ESM reliability and validity. In: De Vries M, ed. Assessing schizophrenia in daily life: the Experience Sampling Method. Maastricht: Maastricht University Press; 1995.
19. Ebner-priemer UW, Eid M, Kleindienst N, Stabenow S, Trull TJ. Analytic strategies for understanding affective (in)stability and other dynamic processes in psychopathology. J Abnorm Psychol 2009;118:195-202.
20. Jahng S, Wood PK, Trull TJ. Analysis of affective instability in ecological momentary assessment: indices using successive difference and group comparison via multilevel modeling. Psychol Meth 2008;13:354-375.
21. Lataster J, Van Os J, De Haan L et al. Emotional experience and estimates of D(2) receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study. J Clin Psychiatry 2011;72:1397-1404.
22. Henquet C, Van Os J, Kuepper R et al. Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry 2010;196:447-453.
23. Dekker N, Linszen DH, De Haan L. Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders. Psychopathology 2009;42:350-360.
24. Green B, Kavanagh DJ, Young RM. Reasons for cannabis use in men with and without psychosis. Drug Alc Rev 2004;23:445-453.
25. Thornton LK, Baker AL, Johnson MP, Lewin TJ. Attitudes and perceptions towards substances among people with mental disorders: a systematic review. Acta Psychiatr Scand 2012;126:87-105.
26. Kolliakou A, Joseph C, Ismail K, Atakan Z, Murray RM. Why do patients with psychosis use cannabis and are they ready to change their use? Int J Dev Neurosci 2011;29:335-346.
27. Robinson TE, Berridge KCAddiction. Annu Rev Psychol 2003;54:25-53.
28. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient compliance with paper and electronic diaries. Contr Clin Trials 2003;24:182-199.
29. Jacobs N, Nicolson NA, Derom C, Delespaul P, Van Os J, Myin-Germeys I. Electronic monitoring of salivary cortisol sampling compliance in daily life. Life Sci 2005;76:2431-2443.
30. Green AS, Rafaeli E, Bolger N, Shrout PE, Reis HT. Paper or plastic? Data equivalence in paper and electronic diaries Psychol Methods 2006;11:87-105.